[HTML][HTML] Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
L Bailón, A Llano, S Cedeño, T Escribà… - Nature Medicine, 2022 - nature.com
HIVACAT T-cell immunogen (HTI) is a novel human immunodeficiency virus (HIV) vaccine
immunogen designed to elicit cellular immune responses to HIV targets associated with viral …
immunogen designed to elicit cellular immune responses to HIV targets associated with viral …
[HTML][HTML] Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
…, A Ward, NN Kinloch, DC Copertino, T Escribà… - Nature …, 2022 - nature.com
In simian-human immunodeficiency virus (SHIV)-infected non-human primates, broadly
neutralizing antibodies (bNAbs) against the virus appear to stimulate T cell immunity. To …
neutralizing antibodies (bNAbs) against the virus appear to stimulate T cell immunity. To …
Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PWH with poor immune reconstitution
…, C Ávila, S Cedeño, T Escribà… - The Journal of …, 2022 - academic.oup.com
Background We analyzed humoral and cellular immune responses induced by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …
[HTML][HTML] Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors
L Egaña-Gorroño, T Escribà, N Boulanger… - PLoS …, 2014 - journals.plos.org
Background The emerging relationship between microRNAs (miRNA) and viral-control is a
topic of interest in the field of HIV. Host-genome might play an important role in the control of …
topic of interest in the field of HIV. Host-genome might play an important role in the control of …
Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy
Objective: The impact of host genetic factors on the incidence of dyslipidemia in antiretroviral-naive
HIV patients starting antiretroviral therapy (ART) is not clear. We assessed the role of …
HIV patients starting antiretroviral therapy (ART) is not clear. We assessed the role of …
Versatile iron–catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy
A novel chemical approach integrating the benefits of nanoparticles with versatility of
coordination chemistry is reported herein to increase the effectiveness of well-known HIV …
coordination chemistry is reported herein to increase the effectiveness of well-known HIV …
[PDF][PDF] Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
…, S González, R Toledo, M Font, S Benet, T Escribà… - Iscience, 2022 - cell.com
Mass vaccination campaigns reduced COVID-19 incidence and severity. Here, we evaluated
the immune responses developed in SARS-CoV-2-uninfected patients with predominantly …
the immune responses developed in SARS-CoV-2-uninfected patients with predominantly …
[HTML][HTML] Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota
…, M Casadellà, L Romero, T Escribà… - npj Biofilms and …, 2022 - nature.com
The gut microbiota is emerging as a crucial factor modulating vaccine responses; however,
few studies have investigated if vaccines, in turn, can alter the microbiota and to what extent …
few studies have investigated if vaccines, in turn, can alter the microbiota and to what extent …
[HTML][HTML] MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: relationship with antiviral immune response and disease progression
…, ME Bargallo, E Planet, E Vilaplana, T Escribà… - PloS one, 2016 - journals.plos.org
Background The relationship between host microRNAs (miRNA), viral control and immune
response has not yet been elucidated in the field of HIV. The aim of this study was to assess …
response has not yet been elucidated in the field of HIV. The aim of this study was to assess …
[HTML][HTML] Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed
O Tort, T Escribà, L Egaña-Gorroño, E de Lazzari… - Journal of Lipid …, 2018 - ASBMB
Cholesterol efflux (CE) capacity has been inversely associated with atherosclerosis and
may provide an insight on inflammation occurring in human immunodeficiency virus (HIV) …
may provide an insight on inflammation occurring in human immunodeficiency virus (HIV) …